antinucleotide
antinucleoside
antinucleosome
heteroclitic
anti-nuclear factor
reagin
polyvalent
-toxa-
antiantibody
ravulizumab
immunomolecule
tislelizumab
brolucizumab
bispecific
olaratumab
guselkumab
pidilizumab
abagovomab
gevokizumab
adecatumumab
-les-
chromobody
affinity reagent
muromonab
cibisatamab
Ab
microlymphocytotoxicity
antipolyvalent
dinutuximab
monoantibody
retifanlimab
sintilimab
solitomab
toripalimab
sasanlimab
antiidiotypic
countercorrelated
pozelimab
vanucizumab
antinucleoprotein
paratope
antiplasma
agonistic monoclonal antibody
zenocutuzumab
antisynthetase
immunoreactant
ziltivekimab
-mab
polyantibody
alloantibody